Haemonetics Corporation Cost of Goods Sold (Deprecated 2018-01-31)
Haemonetics Corporation (HAE) reported Cost of Goods Sold (Deprecated 2018-01-31) of $492.01 million for the 12-month period ending 2018-03-31, per its 10-K filed 2018-05-23.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-05-23
- Haemonetics Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $129.17M, a 11.50% decline year-over-year.
- Haemonetics Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-30 was $122.75M, a 3.17% decline year-over-year.
- Haemonetics Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $120.81M, a 4.15% increase year-over-year.
- Haemonetics Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-07-01 was $119.29M, a 0.32% increase year-over-year.
- Haemonetics Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2018 was $492.01M, a 3.07% decline from fiscal 2017.
- Haemonetics Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $507.62M, a 0.94% increase from fiscal 2016.
- Haemonetics Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $502.92M, a 5.67% increase from fiscal 2015.
- Haemonetics Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $475.95M, a 1.24% increase from fiscal 2014.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $129.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-23 | $251.91M derived: sum of 2 quarters · filed 2018-05-23 | $372.73M derived: sum of 3 quarters · filed 2018-05-23 | $492.01M 10-K · filed 2018-05-23 |
| 2017-12-30 | $122.75M 10-Q · filed 2018-02-06 | $243.56M derived: sum of 2 quarters · filed 2018-02-06 | $362.85M 10-Q · filed 2018-02-06 | $508.80M derived: sum of 4 quarters · filed 2018-05-23 |
| 2017-09-30 | $120.81M 10-Q · filed 2017-11-07 | $240.10M 10-Q · filed 2017-11-07 | $386.06M derived: sum of 3 quarters · filed 2018-05-23 | $512.82M derived: sum of 4 quarters · filed 2018-05-23 |
| 2017-07-01 | $119.29M 10-Q · filed 2017-08-07 | $265.24M derived: sum of 2 quarters · filed 2018-05-23 | $392.00M derived: sum of 3 quarters · filed 2018-05-23 | $508.01M derived: sum of 4 quarters · filed 2018-05-23 |
| 2017-04-01 | $145.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-23 | $272.72M derived: sum of 2 quarters · filed 2018-05-23 | $388.72M derived: sum of 3 quarters · filed 2018-05-23 | $507.62M 10-K · filed 2018-05-23 |
| 2016-12-31 | $126.76M 10-Q · filed 2018-02-06 | $242.77M derived: sum of 2 quarters · filed 2018-02-06 | $361.67M 10-Q · filed 2018-02-06 | $514.79M derived: sum of 4 quarters · filed 2018-05-23 |
| 2016-10-01 | $116.00M 10-Q · filed 2017-11-07 | $234.91M 10-Q · filed 2017-11-07 | $388.02M derived: sum of 3 quarters · filed 2018-05-23 | $512.55M derived: sum of 4 quarters · filed 2018-05-23 |
| 2016-07-02 | $118.90M 10-Q · filed 2017-08-07 | $272.02M derived: sum of 2 quarters · filed 2018-05-23 | $396.55M derived: sum of 3 quarters · filed 2018-05-23 | $510.94M derived: sum of 4 quarters · filed 2018-05-23 |
| 2016-04-02 | $153.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-23 | $277.65M derived: sum of 2 quarters · filed 2018-05-23 | $392.04M derived: sum of 3 quarters · filed 2018-05-23 | $502.92M 10-K · filed 2018-05-23 |
| 2015-12-26 | $124.53M 10-Q · filed 2017-02-06 | $238.93M derived: sum of 2 quarters · filed 2017-02-06 | $349.80M 10-Q · filed 2017-02-06 | $467.91M derived: sum of 4 quarters · filed 2017-05-24 |
| 2015-09-26 | $114.40M 10-Q · filed 2016-11-07 | $225.27M 10-Q · filed 2016-11-07 | $343.38M derived: sum of 3 quarters · filed 2017-05-24 | $463.55M derived: sum of 4 quarters · filed 2017-05-24 |
| 2015-06-27 | $110.87M 10-Q · filed 2016-08-01 | $228.99M derived: sum of 2 quarters · filed 2017-05-24 | $349.15M derived: sum of 3 quarters · filed 2017-05-24 | $468.62M derived: sum of 4 quarters · filed 2017-05-24 |
| 2015-03-28 | $118.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-24 | $238.28M derived: sum of 2 quarters · filed 2017-05-24 | $357.75M derived: sum of 3 quarters · filed 2017-05-24 | $475.95M 10-K · filed 2017-05-24 |
| 2014-12-27 | $120.17M 10-Q · filed 2016-02-02 | $239.63M derived: sum of 2 quarters · filed 2016-02-02 | $357.84M 10-Q · filed 2016-02-02 | $483.49M derived: sum of 4 quarters · filed 2016-06-01 |
| 2014-09-27 | $119.47M 10-Q · filed 2015-11-04 | $237.68M 10-Q · filed 2015-11-04 | $363.33M derived: sum of 3 quarters · filed 2016-06-01 | $483.82M derived: sum of 4 quarters · filed 2016-06-01 |
| 2014-06-28 | $118.21M 10-Q · filed 2015-07-30 | $243.86M derived: sum of 2 quarters · filed 2016-06-01 | $364.35M derived: sum of 3 quarters · filed 2016-06-01 | $480.22M derived: sum of 4 quarters · filed 2016-06-01 |
| 2014-03-29 | $125.65M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-01 | $246.14M derived: sum of 2 quarters · filed 2016-06-01 | $362.01M derived: sum of 3 quarters · filed 2016-06-01 | $470.14M 10-K · filed 2016-06-01 |
| 2013-12-28 | $120.49M 10-Q · filed 2015-02-05 | $236.36M derived: sum of 2 quarters · filed 2015-02-05 | $344.49M 10-Q · filed 2015-02-05 | $471.29M derived: sum of 4 quarters · filed 2015-05-22 |
| 2013-09-28 | $115.87M 10-Q · filed 2014-11-04 | $224.00M 10-Q · filed 2013-10-30 | $350.80M derived: sum of 3 quarters · filed 2015-05-22 | $485.08M derived: sum of 4 quarters · filed 2015-05-22 |
| 2013-06-29 | $108.13M 10-Q · filed 2014-07-31 | $234.93M derived: sum of 2 quarters · filed 2015-05-22 | $369.21M derived: sum of 3 quarters · filed 2015-05-22 | $485.63M derived: sum of 4 quarters · filed 2015-05-22 |
| 2013-03-30 | $126.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-22 | $261.08M derived: sum of 2 quarters · filed 2015-05-22 | $377.50M derived: sum of 3 quarters · filed 2015-05-22 | $463.86M 10-K · filed 2015-05-22 |
| 2012-12-29 | $134.28M 10-Q · filed 2014-01-30 | $250.70M derived: sum of 2 quarters · filed 2014-01-30 | $337.06M 10-Q · filed 2014-01-30 | $429.12M derived: sum of 4 quarters · filed 2014-05-22 |
| 2012-09-29 | $116.42M 10-Q · filed 2013-10-30 | $202.78M 10-Q · filed 2013-10-30 | $294.84M derived: sum of 3 quarters · filed 2014-05-22 | $390.07M derived: sum of 4 quarters · filed 2014-05-22 |
| 2012-06-30 | $86.36M 10-Q · filed 2013-08-02 | $178.42M derived: sum of 2 quarters · filed 2014-05-22 | $273.65M derived: sum of 3 quarters · filed 2014-05-22 | $363.15M derived: sum of 4 quarters · filed 2014-05-22 |
| 2012-03-31 | $92.06M derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-22 | $187.29M derived: sum of 2 quarters · filed 2014-05-22 | $276.78M derived: sum of 3 quarters · filed 2014-05-22 | $358.60M 10-K · filed 2014-05-22 |
| 2011-12-31 | $95.23M 10-Q · filed 2013-02-01 | $184.72M derived: sum of 2 quarters · filed 2013-02-01 | $266.55M 10-Q · filed 2013-02-01 | $349.08M derived: sum of 4 quarters · filed 2013-05-20 |
| 2011-10-01 | $89.50M 10-Q · filed 2012-11-07 | $171.32M 10-Q · filed 2012-11-07 | $253.85M derived: sum of 3 quarters · filed 2013-05-20 | $337.15M derived: sum of 4 quarters · filed 2013-05-20 |
| 2011-07-02 | $81.82M 10-Q · filed 2012-08-08 | $164.35M derived: sum of 2 quarters · filed 2013-05-20 | $247.65M derived: sum of 3 quarters · filed 2013-05-20 | $326.73M derived: sum of 4 quarters · filed 2013-05-20 |
| 2011-04-02 | $82.53M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-20 | $165.83M derived: sum of 2 quarters · filed 2013-05-20 | $244.91M derived: sum of 3 quarters · filed 2013-05-20 | $321.49M 10-K · filed 2013-05-20 |
| 2011-01-01 | $83.30M 10-Q · filed 2012-02-06 | $162.38M derived: sum of 2 quarters · filed 2012-02-06 | $238.95M 10-Q · filed 2012-02-06 | $319.93M derived: sum of 4 quarters · filed 2012-05-22 |
| 2010-10-02 | $79.08M 10-Q · filed 2011-11-03 | $155.66M 10-Q · filed 2011-11-03 | $236.63M derived: sum of 3 quarters · filed 2012-05-22 | $316.36M derived: sum of 4 quarters · filed 2012-05-22 |
| 2010-07-03 | $76.58M 10-Q · filed 2011-08-10 | $157.56M derived: sum of 2 quarters · filed 2012-05-22 | $237.28M derived: sum of 3 quarters · filed 2012-05-22 | $313.38M derived: sum of 4 quarters · filed 2012-05-22 |
| 2010-04-03 | $80.98M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-22 | $160.70M derived: sum of 2 quarters · filed 2012-05-22 | $236.81M derived: sum of 3 quarters · filed 2012-05-22 | $307.95M 10-K · filed 2012-05-22 |
| 2009-12-26 | $79.72M 10-Q · filed 2011-02-08 | $155.82M derived: sum of 2 quarters · filed 2011-02-08 | $226.97M 10-Q · filed 2011-02-08 | |
| 2009-09-26 | $76.10M 10-Q · filed 2010-11-10 | $147.25M 10-Q · filed 2010-11-10 | ||
| 2009-06-27 | $71.14M 10-Q · filed 2010-08-11 | |||
| 2009-03-28 | $289.71M 10-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |